Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00387179
Other study ID # 406
Secondary ID M01RR000051R01HL
Status Recruiting
Phase N/A
First received October 11, 2006
Last updated August 24, 2009
Start date October 2006
Est. completion date March 2010

Study information

Verified date August 2009
Source National Heart, Lung, and Blood Institute (NHLBI)
Contact Gayle Wright, MS
Phone 303-735-1923
Email Sleep.Study@colorado.edu
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

Jet lag and some sleep disorders are caused by a disruption in an individual's "internal clock." Understanding the most effective way to quickly re-adjust the body's internal clock will be beneficial for treating individuals with these conditions. This study will evaluate the combined effectiveness of light and non-light therapies at regulating sleep cycles and improving sleep quality.


Description:

Circadian rhythm disorders are disruptions in an individual's circadian rhythm, or "internal body clock." This internal clock regulates the 24-hour cycle of biological processes in the body, including sleep and hormone production. Jet lag, delayed sleep phase syndrome, in which individuals fall asleep and wake up later than desired, and advanced sleep phase syndrome, in which individuals fall asleep and wake up earlier than desired, are all examples of circadian rhythm disorders. Because of the disruptive nature of these conditions, it is important to identify the quickest and most effective method for regulating the body and reestablishing normal sleep patterns. Light therapy, in which individuals are exposed to bright, artificial light, is currently used to treat these disorders. Melatonin, a hormone that regulates circadian rhythms, and methylxanthines, a class of stimulant medications, are other common non-light treatments. While each of these individual treatments has been proven effective, little is known about the combined effect of light and non-light treatments. The purpose of this study is to evaluate the safety and effectiveness of light therapy, melatonin, and methylxanthine, alone and in combination, at regulating circadian rhythms and improving sleep quality and cognitive function.

This study will enroll healthy individuals. Participants will first attend two screening visits, which will include a review of medical, psychiatric, and sleep histories; vital sign measurements; blood and urine collection; a physical examination; and an electrocardiogram. For 1 week, participants will record sleep habits in a diary and by telephone. They will also wear a device that monitors activity and light exposure levels. Eligible participants will then attend four 5-day inpatient visits at the Sleep and Chronobiology Laboratory at the University of Colorado at Boulder. During each of the four visits, participants will be randomly assigned to one of the following four treatments:

- Dim light therapy and placebo

- Bright light therapy and placebo

- Dim light therapy, melatonin, and methylxanthines

- Bright light therapy, melatonin, and methylxanthines

At each visit, participants will receive a different treatment. During these visits, participants will remain awake for up to 40 hours at a time, while their eye movements, and brain, muscle, heart, and breathing activity are monitored. Urine and saliva will be collected, and participants will undergo various cognitive performance testing measures. At 3-week intervals between each visit, participants will record sleep habits and will wear the activity and light exposure monitoring device. A sleep diary will also be maintained by participants for 3 weeks following the end of the last visit.


Recruitment information / eligibility

Status Recruiting
Enrollment 48
Est. completion date March 2010
Est. primary completion date March 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- In good general health, as determined by blood chemistries, urine toxicology, physical examination, and medical and psychiatric history

Exclusion Criteria:

- History of any current or chronic disease, including any of the following:

1. Chronobiologic disorders

2. Sleep disorders

3. Cardiovascular disorders

4. Respiratory disorders

5. Kidney and urinary tract disorders

6. Infectious diseases

7. Gastrointestinal disorders

8. Immune system disorders

9. Connective tissue and joint disorders

10. Hematopoietic disorders

11. Neoplastic diseases

12. Endocrine and metabolic diseases

13. Neurologic disorders

- Current or past history of drug abuse

- Pregnant or breastfeeding

- Current oral contraceptive use

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Drug:
Melatonin
5mg, pill, once
Methylxanthine
2.9 mg/kg, pill, once
Procedure:
Light Therapy
Bright light exposure

Locations

Country Name City State
United States Sleep and Chronobiology Laboratory Boulder Colorado

Sponsors (1)

Lead Sponsor Collaborator
National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

References & Publications (8)

Barger LK, Wright KP Jr, Hughes RJ, Czeisler CA. Daily exercise facilitates phase delays of circadian melatonin rhythm in very dim light. Am J Physiol Regul Integr Comp Physiol. 2004 Jun;286(6):R1077-84. Epub 2004 Mar 18. — View Citation

Duffy JF, Wright KP Jr. Entrainment of the human circadian system by light. J Biol Rhythms. 2005 Aug;20(4):326-38. Review. — View Citation

Gronfier C, Wright KP Jr, Kronauer RE, Jewett ME, Czeisler CA. Efficacy of a single sequence of intermittent bright light pulses for delaying circadian phase in humans. Am J Physiol Endocrinol Metab. 2004 Jul;287(1):E174-81. Epub 2004 Mar 23. — View Citation

Wright KP Jr, Badia P, Myers BL, Plenzler SC, Hakel M. Caffeine and light effects on nighttime melatonin and temperature levels in sleep-deprived humans. Brain Res. 1997 Jan 30;747(1):78-84. — View Citation

Wright KP Jr, Czeisler CA. Absence of circadian phase resetting in response to bright light behind the knees. Science. 2002 Jul 26;297(5581):571. — View Citation

Wright KP Jr, Gronfier C, Duffy JF, Czeisler CA. Intrinsic period and light intensity determine the phase relationship between melatonin and sleep in humans. J Biol Rhythms. 2005 Apr;20(2):168-77. — View Citation

Wright KP Jr, Hughes RJ, Kronauer RE, Dijk DJ, Czeisler CA. Intrinsic near-24-h pacemaker period determines limits of circadian entrainment to a weak synchronizer in humans. Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):14027-32. — View Citation

Wright KP Jr, Myers BL, Plenzler SC, Drake CL, Badia P. Acute effects of bright light and caffeine on nighttime melatonin and temperature levels in women taking and not taking oral contraceptives. Brain Res. 2000 Aug 11;873(2):310-7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Circadian phase, as measured by the shift of the endogenous melatonin rhythm (measured during each inpatient visit) 24 hour No
Secondary Circadian phase, as measured by the shift of the endogenous temperature rhythm 24 hour No
Secondary Sleep quality, as measured by wakefulness after sleep onset (electroencephalogram [EEG] defined wakefulness after 10 minutes of consecutive sleep) and number of awakenings overnight No
Secondary Cognitive function, as measured by daytime sleepiness, reaction time, and mood and well being (all measured during each inpatient visit) 24 h and daytime No
See also
  Status Clinical Trial Phase
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Recruiting NCT05991453 - Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial N/A
Withdrawn NCT05096130 - Lifestyle Medicine Strategies for Combating Sleepiness and Fatigue in Professional Drivers N/A
Completed NCT01327040 - Light Sensitization Study N/A
Completed NCT00593736 - Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase Syndrome Phase 2
Recruiting NCT04900675 - Bright Light Intervention to Reduce Students' Stress N/A
Completed NCT01881854 - Sleep Wake and Melatonin Pattern in Craniopharyngioma N/A
Completed NCT00246051 - Comprehensive Police Fatigue Management Program N/A
Recruiting NCT04690504 - Validation of Circadian Biomarkers in Patients With Sleep Disorders
Completed NCT03363529 - ROOM-LIGHT: Dynamic LED-light as Treatment for Depressed Patients in Inpatient Wards N/A
Recruiting NCT05701969 - Effect of Melatonin on Sleep Patterns of Resident Trainees During Night Float Shift Early Phase 1
Completed NCT00723580 - Actigraphic Analysis of Treatment Response N/A
Completed NCT00207285 - Sleep Disorders Management, Health and Safety in Police N/A
Not yet recruiting NCT06336525 - Adult Sleep Health in the Rural Appalachia and Mississippi Delta Region and Its Relationships With Cardiometabolic Health Disparities.
Not yet recruiting NCT06181110 - Sleep-Wake Patterns on Illness Trajectories and Treatment Response in MDD N/A
Recruiting NCT05618405 - Changes in Circadian Rhythm After Anaesthesia in Children
Completed NCT05684523 - Feasibility Study on the Use of Redormin®500 on Day-time Cognition Phase 4
Recruiting NCT05247125 - The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Interventional) Phase 4
Completed NCT04219566 - Vestibular Nerve Stimulation to Improve Sleep N/A
Completed NCT02199847 - Evaluation of the Effects of Pharmaton Tablets on Mental Performance and Physical Fatigue in Nurses Working Night Shift Phase 2